Reliability of the MODS assay decentralisation process in three health regions in Peru

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 2, 2011, Pages 217-222

  Mendoza, A ^a   Castillo, E ^b   Gamarra, N ^c   Huaman T ^c   Perea, M ^d   Monroi, Y ^d   Salazar, R ^a   Coronel, J ^e   Acurio, M ^a   Obregon G ^a   Roper, M ^e   Bonilla, C ^f   Asencios, L ^a   Moore, D A J ^e,g  

^a INSTITUTO NACIONAL DE SALUD   (Peru)

^b Laboratorio Regional   (Peru)

^c Laboratorio Regional   (Peru)

^d Dir de Salud de Arequipa   (Peru)

^e UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^f Ministerio de Salud   (Peru)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Decentralisation; MDR TB; MODS assay; Peru

Indexed keywords

ISONIAZID; RIFAMPICIN;

ARTICLE; BACTERIUM CONTAMINATION; DRUG SENSITIVITY; MULTIDRUG RESISTANT TUBERCULOSIS; PERU; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS;

EID: 78651456284     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization. Tuberculosis en las Américas. Reporte regional 2009. HSD/CD/T/002-10. Geneva, Switzerland: WHO, 2009. [Spanish]
2. World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2004.
3. Del Castillo H, Mendoza A, Saravia J, Somocurcio J. Epidemia de tuberculosis multidrogo-resistente y extensivamente resistente a drogas en el Perú: situación y propuestas para su control. Rev Peru Med Exp Salud Publica 2009; 26: 380-386. [Spanish]
4. Mendoza A, Asencios L, Quispe N, Leo E. Evidencia de tuberculosis con resistencia extendida a drogas de segunda línea (TB-XDR) en el Perú. Rev Peru Med Exp Salud Publica 2007; 24: 313-314. [Spanish]
5. Bonilla C A, Crossa A, Jave H O, et al. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS One 2008; 3: e2957.
6. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/ 2008.402. Geneva, Switzerland: WHO, 2008.
7. Caviedes L, Lee T-S, Gilman R H, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208.
8. Moore D A, Evans C A, Gilman R H, et al. Microscopico bservation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550.
9. Shiferaw G, Woldeamanuel Y, Gebeyehu M, et al. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1093-1097.
10. Arias M, Mello F C, Pavon A, et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44: 674-680.
11. Michael J S, Daley P, Kalaiselvan S, Latha A, et al. Diagnostic accuracy of the microscopic observation drug susceptibility assay: a pilot study from India. Int J Tuberc Lung Dis 2010; 14: 482-488.
12. Estrategia Sanitaria Nacional de Prevención y Control de la Tuberculosis, Ministerio de Salud. Situación de la tuberculosis en el Perú. Informe de gestión-2008. Lima, Peru: MINSA, 2008. ftp://ftp2.minsa.gob.pe/descargas/dgsp/ESN-tuberculosis/ normaspublicaciones/ InfEvaluacion2008.pdf Accessed December 2010. [Spanish]
13. Asencios L, Quispe N, Mendoza A, et al. Vigilancia nacional de la resistencia a medicamentos antituberculosos, Perú 2005- 2006. Rev Peru Med Exp Salud Publica 2009; 26: 278-287. [Spanish]
14. Moore D, Mendoza D, Gilman R, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resourcepoor settings. J Clin Microbiol 2004; 42: 4432-4437.
15. Johnston J C, Shahidi N C, Sadatsafavi M, Fitzgerald J M. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One 2009; 4: e6914.
16. Dowdy D W, Chaisson R E, Maartens G, Corbett E L, Dorman S E. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci USA 2008; 105: 11293-11298.
17. Tovar M, Siedner M J, Gilman R H, et al. Improved diagnosis of pleural tuberculosis using the microscopic-observation drugsusceptibility technique. Clin Infect Dis 2008; 46: 909-912.
18. Caws M, Dang T M, Torok E, et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS One 2007; 2: e1173.
19. Reddy K P, Brady M F, Gilman R H, et al. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis 2010; 50: 997-999.
20. Perea M, Delgado F, Monroi Y, et al. Validación de la prueba MODS en el Laboratorio Regional de Arequipa. In: Abstract book, 40th World Conference on Lung Heath of the International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis 2009; 13 (Suppl 1): S123.
21. Park W G, Bishai W R, Chaisson R E, Dorman S E. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 4750-4752.
22. Ejigu G S, Woldeamanuel Y, Shah N S, et al. Microscopico bservation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis 2010; 12: 332-337.
23. Laszlo A, Rahman M, Espinal M, Raviglione M; WHO/ IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002; 6: 748-756.
24. Coronel J, Roper M, Mitchel S, et al. MODS accreditation process for regional reference laboratories in Peru-validation by Genotype® MTBDR-plus. Int J Tuberc Lung Dis 2010; 14: 1475-1480.
25. Zimic M, Velazco A, Comina G, et al. Development of lowcost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture. PLoS One 2010; 5: e9577.